Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heterogeneity of commercial timothy grass pollen extracts.
Focke M, Marth K, Flicker S, Valenta R. Focke M, et al. Among authors: marth k. Clin Exp Allergy. 2008 Aug;38(8):1400-8. doi: 10.1111/j.1365-2222.2008.03031.x. Epub 2008 Jun 28. Clin Exp Allergy. 2008. PMID: 18564332
Tracing antigen signatures in the human IgE repertoire.
Marth K, Novatchkova M, Focke-Tejkl M, Jenisch S, Jäger S, Kabelitz D, Valenta R. Marth K, et al. Mol Immunol. 2010 Aug;47(14):2323-9. doi: 10.1016/j.molimm.2010.05.285. Epub 2010 Jun 22. Mol Immunol. 2010. PMID: 20573403 Free PMC article.
Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A, Cejka P, Blatt K, Focke-Tejkl M, Linhart B, Flicker S, Stoecklinger A, Marth K, Drescher A, Thalhamer J, Valent P, Majdic O, Valenta R. Gieras A, et al. Among authors: marth k. J Immunol. 2011 May 1;186(9):5333-44. doi: 10.4049/jimmunol.1000804. Epub 2011 Mar 30. J Immunol. 2011. PMID: 21451110
Recombinant allergens: what does the future hold?
Valenta R, Niespodziana K, Focke-Tejkl M, Marth K, Huber H, Neubauer A, Niederberger V. Valenta R, et al. Among authors: marth k. J Allergy Clin Immunol. 2011 Apr;127(4):860-4. doi: 10.1016/j.jaci.2011.02.016. J Allergy Clin Immunol. 2011. PMID: 21458656 Review.
The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils.
Blatt K, Herrmann H, Mirkina I, Hadzijusufovic E, Peter B, Strommer S, Hoermann G, Mayerhofer M, Hoetzenecker K, Klepetko W, Ghanim V, Marth K, Füreder T, Wacheck V, Valenta R, Valent P. Blatt K, et al. Among authors: marth k. PLoS One. 2012;7(1):e29925. doi: 10.1371/journal.pone.0029925. Epub 2012 Jan 27. PLoS One. 2012. PMID: 22299028 Free PMC article.
40 results